Vicarious Surgical's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Vicarious Surgical (NYSE:RBOT) is anticipated to report a Q4 earnings per share (EPS) of $-0.12 on March 4, 2024. Analysts and investors are keen on whether the company will surpass this estimate and provide positive future guidance. Historically, Vicarious Surgical's stock price has been significantly affected by its earnings performance and guidance, with a notable 42.63% drop after last quarter's earnings beat. The stock has seen an 84.71% decline over the last 52 weeks, trading at $0.4244 as of February 29.
March 01, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Vicarious Surgical is expected to report a Q4 EPS of $-0.12, with investor focus on potential earnings beat and future guidance. The stock has experienced significant volatility post-earnings in the past and is currently down 84.71% over the last year.
Given Vicarious Surgical's history of stock price volatility post-earnings and the significant decline over the past year, the upcoming earnings report could maintain the stock's current trajectory or potentially reverse it, depending on whether the company beats the EPS estimate and provides positive guidance. However, the stock's recent performance and the uncertainty surrounding the earnings outcome contribute to a neutral short-term impact score.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100